Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.790,56
0,10%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zhongchao Inc (ZCMD) Zhongchao Inc (ZCMD) Notizie

ZCMD

Zhongchao (ZCMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZCMD
DataOraFonteTitoloSimboloCompagnia
12/03/202413:30PR Newswire (US)Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of MedicationsNASDAQ:ZCMDZhongchao Inc
29/02/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ZCMDZhongchao Inc
27/02/202414:00PR Newswire (US)Zhongchao Inc. Announces 1-for-10 Share ConsolidationNASDAQ:ZCMDZhongchao Inc
11/12/202314:00PR Newswire (US)Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsNASDAQ:ZCMDZhongchao Inc
23/10/202314:00PR Newswire (US)Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DayNASDAQ:ZCMDZhongchao Inc
25/09/202314:00PR Newswire (US)Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsNASDAQ:ZCMDZhongchao Inc
24/08/202314:00PR Newswire (US)Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease ManagementNASDAQ:ZCMDZhongchao Inc
11/07/202314:00PR Newswire (US)Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer EducationNASDAQ:ZCMDZhongchao Inc
12/06/202314:00PR Newswire (US)Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and TreatmentNASDAQ:ZCMDZhongchao Inc
23/05/202323:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ZCMDZhongchao Inc
12/05/202314:00PR Newswire (US)Zhongchao Inc. Announces Strategic Cooperation with XimalayaNASDAQ:ZCMDZhongchao Inc
12/05/202312:04Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ZCMDZhongchao Inc
08/05/202314:00PR Newswire (US)Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in ChinaNASDAQ:ZCMDZhongchao Inc
28/04/202322:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:ZCMDZhongchao Inc
24/04/202314:00PR Newswire (US)Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' HealthNASDAQ:ZCMDZhongchao Inc
30/03/202314:00PR Newswire (US)Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production PlatformNASDAQ:ZCMDZhongchao Inc
13/03/202313:00PR Newswire (US)Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full SatisfactionNASDAQ:ZCMDZhongchao Inc
23/02/202314:00PR Newswire (US)Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)NASDAQ:ZCMDZhongchao Inc
13/02/202315:20PR Newswire (US)Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment EfficiencyNASDAQ:ZCMDZhongchao Inc
08/02/202313:30PR Newswire (US)Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and ExperienceNASDAQ:ZCMDZhongchao Inc
31/01/202313:30PR Newswire (US)Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to ChinaNASDAQ:ZCMDZhongchao Inc
19/01/202313:30PR Newswire (US)Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer TreatmentNASDAQ:ZCMDZhongchao Inc
04/01/202313:30PR Newswire (US)Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma LimitedNASDAQ:ZCMDZhongchao Inc
05/12/202213:30PR Newswire (US)Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education PlatformNASDAQ:ZCMDZhongchao Inc
03/11/202212:30PR Newswire (US)Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation MarketNASDAQ:ZCMDZhongchao Inc
28/09/202215:18PR Newswire (US)Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to MedicationsNASDAQ:ZCMDZhongchao Inc
15/09/202213:30PR Newswire (US)Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major DiseasesNASDAQ:ZCMDZhongchao Inc
01/09/202213:30PR Newswire (US)Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease ManagementNASDAQ:ZCMDZhongchao Inc
13/06/202212:30PR Newswire (US)Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management CourseNASDAQ:ZCMDZhongchao Inc
09/05/202212:30PR Newswire (US)Zhongchao Inc. Reports the Fiscal Year 2021 Financial ResultsNASDAQ:ZCMDZhongchao Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZCMD

La tua Cronologia

ASX
VP7
Velocity Property
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network